Androgen deficiency in women and possibilities for its hormonal diagnostics
https://doi.org/10.14341/probl201157331-36
Abstract
The authors describe the distribution patterns of free testosterone concentrations in the saliva of women who previously underwent ovariectomy, in postmenopausal women, in those presenting with clinical signs of hyperandrogenism, and in healthy women in the follicular phase of the menstrual cycle. The level of salivary free testosterone in postmenopausal women and after ovariectomy was lower than in younger premenopausal patients. Women with clinical signs of hyperandrogenism showed higher free testosterone levels than the age-matched young healthy subjects. The salivary free testosterone levels in 60-75% of the ovariectomzed, postmenopausal, and hyperandogenic women remained within their normal range in young healthy women. It is concluded that high analytical sensitivity of the chemiluminescent method for the measurement of free testosterone in the saliva makes possible its application to the screening for androgen status of the women at risk of testosterone deficiency.
References
1. Burger H.G. Androgen production in women. Fertil Steril 2002;77:Suppl 4:S3-S5.
2. Sherwin B.B., Gelfand M.M. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:4:397-409.
3. Panay N., Al-Azzawi F., Bouchard C. et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010;13:2:121-131.
4. Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:6:537-544.
5. Bachmann G.A., Leiblum S.R. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004;11:1:120-130.
6. Castelo-Branco C., Blumel J.E., Araya H. et al. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol 2003;23:4:426-430.
7. González M., Viáfara G., Caba F., Molina E. Sexual function, menopause and hormone replacement therapy (HRT). Maturitas 2004;48:4:411-420.
8. Nappi R. Androgens and postmenopausal sexuality. Proceedings 8th European congress of menopause. London 2009;S10.
9. Rosner W., Auchus R.J., Azziz R. et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:2:405-413.
10. Гончаров Н.П., Кация Г.В., Колесникова Г.С. и др. Сравнительный анализ определения тестостерона в сыворотке крови различными методами. Пробл эндокринол 2005;51:6:31-37.
11. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:10:3666-3672.
12. Adashi E.Y. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril 1994;62:1:20-27.
13. Burger H.G., Dudley E.C., Hopper J.L. et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:12:3537-3545.
14. Burger H.G., Dudley E.C., Cui J. et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:8:2832-2838.
15. Sowers M.R., Jannausch M., Randolph J.F. et. al. Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. J Clin Endocrinol Metab 2005;90:11:6064-6071.
16. Wierman M.E., Basson R., Davis S.R. et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006;91:10:3697-3710.
17. Rivera-Woll L.M., Papalia M., Davis S.R., Burger H.G. Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update 2004;10:5:421-432.
18. Cappola A.R., Xue Q.L., Fried L.P. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 2009;64:2:243-248.
19. Bachmann G., Bancroft J., Braunstein G. et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:4:660-665.
20. Crabbe P., Bogaert V., De Bacquer D. et al. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab 2007;92:9:3604-3610.
21. Chen J., Sowers M.R., Moran F.M. et al. Circulating bioactive androgens in midlife women. J Clin Endocrinol Metab 2006;91:11:4387-4394.
22. Dunbar N., Gruman C., Reisine S., Kenny A.M. Comparison of two health status measures and their associations with testosterone levels in older men. Aging Male 2001;4:1-7.
23. Tsujimura A., Matsumiya K., Miyagawa Y. et al. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Impot Res 2005;17:3:259-263.
24. Smith K.W., Feldman H.A., McKinlay J.B. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxford) 2000;53:6:703-711.
25. Heinemann L.A., Zimmerman T., Vermeulen A. et al. A new «aging males» symptoms rating scale. Aging Male 1999;2:105-114.
Review
For citations:
Goncharov N.P., Katsiia G.V., Melikhova O.A., Smetnik V.P. Androgen deficiency in women and possibilities for its hormonal diagnostics. Problems of Endocrinology. 2011;57(3):31-36. (In Russ.) https://doi.org/10.14341/probl201157331-36
Views:
417
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
